134 related articles for article (PubMed ID: 26647303)
1. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system.
Xu Z; Li J; Wu Y; Sun Z; Luo L; Hu Z; He S; Zheng J; Zhang H; Zhang X
Eur J Med Chem; 2016 Jan; 108():154-165. PubMed ID: 26647303
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold.
Xu Z; Xu X; O'Laoi R; Ma H; Zheng J; Chen S; Luo L; Hu Z; He S; Li J; Zhang H; Zhang X
Bioorg Med Chem; 2016 Nov; 24(22):5861-5872. PubMed ID: 27692509
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design.
Poulsen A; Ho SY; Wang W; Alam J; Jeyaraj DA; Ang SH; Tan ES; Lin GR; Cheong VW; Ke Z; Lee MA; Keller TH
J Chem Inf Model; 2015 Jul; 55(7):1435-48. PubMed ID: 26024410
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Optimization of a Porcupine Inhibitor.
Duraiswamy AJ; Lee MA; Madan B; Ang SH; Tan ES; Cheong WW; Ke Z; Pendharkar V; Ding LJ; Chew YS; Manoharan V; Sangthongpitag K; Alam J; Poulsen A; Ho SY; Virshup DM; Keller TH
J Med Chem; 2015 Aug; 58(15):5889-99. PubMed ID: 26110200
[TBL] [Abstract][Full Text] [Related]
6. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Shah K; Panchal S; Patel B
Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
[TBL] [Abstract][Full Text] [Related]
7. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
[TBL] [Abstract][Full Text] [Related]
8. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
[TBL] [Abstract][Full Text] [Related]
9. The development of highly potent inhibitors for porcupine.
Wang X; Moon J; Dodge ME; Pan X; Zhang L; Hanson JM; Tuladhar R; Ma Z; Shi H; Williams NS; Amatruda JF; Carroll TJ; Lum L; Chen C
J Med Chem; 2013 Mar; 56(6):2700-4. PubMed ID: 23477365
[TBL] [Abstract][Full Text] [Related]
10. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine.
Dodge ME; Moon J; Tuladhar R; Lu J; Jacob LS; Zhang LS; Shi H; Wang X; Moro E; Mongera A; Argenton F; Karner CM; Carroll TJ; Chen C; Amatruda JF; Lum L
J Biol Chem; 2012 Jun; 287(27):23246-54. PubMed ID: 22593577
[TBL] [Abstract][Full Text] [Related]
11. An
Asciolla JJ; Miele MM; Hendrickson RC; Resh MD
J Biol Chem; 2017 Aug; 292(33):13507-13513. PubMed ID: 28655768
[TBL] [Abstract][Full Text] [Related]
12. Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors.
Ho SY; Alam J; Jeyaraj DA; Wang W; Lin GR; Ang SH; Tan ESW; Lee MA; Ke Z; Madan B; Virshup DM; Ding LJ; Manoharan V; Chew YS; Low CB; Pendharkar V; Sangthongpitag K; Hill J; Keller TH; Poulsen A
J Med Chem; 2017 Aug; 60(15):6678-6692. PubMed ID: 28671458
[TBL] [Abstract][Full Text] [Related]
13. The use of porcupine inhibitors to target Wnt-driven cancers.
Ho SY; Keller TH
Bioorg Med Chem Lett; 2015 Dec; 25(23):5472-6. PubMed ID: 26522946
[TBL] [Abstract][Full Text] [Related]
14. Delivery of the Porcupine Inhibitor WNT974 in Mice.
Zhang LS; Lum L
Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157
[TBL] [Abstract][Full Text] [Related]
15. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.
Moon J; Zhou H; Zhang LS; Tan W; Liu Y; Zhang S; Morlock LK; Bao X; Palecek SP; Feng JQ; Williams NS; Amatruda JF; Olson EN; Bassel-Duby R; Lum L
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1649-1654. PubMed ID: 28143939
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
[TBL] [Abstract][Full Text] [Related]
17. Efficient synthesis of new phenanthridine Wnt/β-catenin signaling pathway agonists.
Chen D; Zhang H; Jing C; He X; Yang B; Cai J; Zhou Y; Song X; Li L; Hao X
Eur J Med Chem; 2018 Sep; 157():1491-1499. PubMed ID: 30282321
[TBL] [Abstract][Full Text] [Related]
18. Chemical Modulation of WNT Signaling in Cancer.
Zhang LS; Lum L
Prog Mol Biol Transl Sci; 2018 Jan; 153():245-269. PubMed ID: 29389519
[TBL] [Abstract][Full Text] [Related]
19. Development of a triazole class of highly potent Porcn inhibitors.
You L; Zhang C; Yarravarapu N; Morlock L; Wang X; Zhang L; Williams NS; Lum L; Chen C
Bioorg Med Chem Lett; 2016 Dec; 26(24):5891-5895. PubMed ID: 27876319
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer.
Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM
Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
